What's been buzzing the loudest for me so far at HLTH Europe? AI, AI, and more AI, of course. Tongues have been tripping over those two letters in every conversation I've had today or listened to including these nuggets: Michael Chen of Nuclera: "Generative AI is wonderful because it brings more hypothesis-making power for the drug discovery researcher. But ultimately, we all know that AI isn't enough. You need to have the power at the wet lab benchtop in order to validate experiments and bring hits and needs into the local trials, and the quality of these hits and leads that ultimately will help the success rates in phase one through three clinical trials, which often don't rear their ugly heads until it's too late." Geraldine O'Keeffe of EQT Group: "There's a huge amount of investment opportunity in terms of AI-, SaaS-based models, in big data and machine learning in diagnostics, precision medicine...delivering the care you need better, faster, cheaper." Karen DeSalvo of Google: "The availability of AI, the ubiquity of it, and just how quickly that is moving [has been significant in the evolution of AI in healthcare]. What I'm hoping now is the next generation of this technology allows us to democratise access to health for people all over the world, and that we can start to do that much more quickly and much more equitably." Chiara Bucciarelli-Ducci, MD, PhD and Marlies Schijven on clinicians' take on AI: "To scale up adoption of AI in healthcare, industry needs to demonstrate to clinicians and healthcare providers the cost effectiveness and cost efficiencies that the technology can bring at every level." "More often than not, we find that AI does work and helps to bring efficiencies, but it also carries risk. So it needs to be properly explained." Agree, disagree, or follow-up comments on these soundbites? #genAI #AIeverywhere #medicalAI #healthtech #digitalhealth #AIfordrugdiscovery #techbio #healthAI #clinicalAI
Tina Tan’s Post
More Relevant Posts
-
Verification of Gen AI in Clinical Decision-Making At Healthcare CoPilot, we’re thrilled about the potential of generative AI to aid in clinical decision-making. However, these technologies are unsafe without the correct supporting knowledge architecture and verification approaches. Over 75% of our efforts are focused on verifying the performance and safety of LEO, our AI agent, and we are continually seeking opportunities to improve. A recent find by our Clinical Evaluation team for ISO13485 has been incorporated into our QMS. Bragazzi, N. L., & Garbarino, S. (2024). Toward Clinical Generative AI: Conceptual Framework. JMIR AI, 3, e55957. doi: 10.2196/55957 advocates for a “clinically explainable, fair, and responsible clinician-, expert-, and patient-in-the-loop AI.” This means AI will serve as a transparent and ethical augmentative tool to clinicians, not a replacement. #MoveFastButDontBreakAnything #HealthcareInnovation #GenerativeAI #ClinicalDecisionMaking #PatientCare #AIinHealthcare #LEObyHealthcareCoPilot Microsoft for Startups Microsoft for Healthcare William Maw Robert Smith Mary Willhoeft Steve Boam Ian Smith Darren Jones Sally Ann Frank
To view or add a comment, sign in
-
The #MAPSPR24 meeting had several sessions on artificial intelligence (AI) and concluded with a panel highlighting the transformative potential of AI in the medical field. As we embark on this journey, it's essential to recognize the ethical, regulatory, and societal implications of AI in Medical Affairs (MA). Collaboration between industry stakeholders, policymakers, and healthcare professionals is paramount to harnessing AI's full potential and ensuring data is leveraged in an appropriate and unbiased way. Creating distinctive pilots in AI is crucial to lay the foundation for successful implementation and increased productivity. Anticipating imperfection is key. It allows organizations to identify challenges, refine strategies before scaling, and foster a culture of continuous improvement. This approach instills confidence and paves the way for successful AI deployments. The future of AI in MA is bright, brimming with opportunities to redefine healthcare delivery, empower patients, and drive scientific innovation. Let's embrace this paradigm shift with optimism, curiosity, and a commitment to harnessing technology for the betterment of global health. Together, we can shape a future where AI serves as a catalyst for positive change in the MA world! What challenges do you foresee in implementing AI solutions in medical affairs? How can these challenges be addressed? #AI #ArtificialIntelligence #HealthcareInnovation #FutureofMedicalAffairs #MAPSPR24 #JoinTheMovement
To view or add a comment, sign in
-
-
TGIF! How do you envision AI shaping the future of patient-provider communications in healthcare? It's here and it's happening. 😊 Take a look at the learnings from #MAPSPR24 and how Symbiotix can help you leverage AI to power your medical communications. #AI # ArtificialIntelligence #HealthcareInnovation #FutureofMedicalAffairs #JoinTheMovement
The #MAPSPR24 meeting had several sessions on artificial intelligence (AI) and concluded with a panel highlighting the transformative potential of AI in the medical field. As we embark on this journey, it's essential to recognize the ethical, regulatory, and societal implications of AI in Medical Affairs (MA). Collaboration between industry stakeholders, policymakers, and healthcare professionals is paramount to harnessing AI's full potential and ensuring data is leveraged in an appropriate and unbiased way. Creating distinctive pilots in AI is crucial to lay the foundation for successful implementation and increased productivity. Anticipating imperfection is key. It allows organizations to identify challenges, refine strategies before scaling, and foster a culture of continuous improvement. This approach instills confidence and paves the way for successful AI deployments. The future of AI in MA is bright, brimming with opportunities to redefine healthcare delivery, empower patients, and drive scientific innovation. Let's embrace this paradigm shift with optimism, curiosity, and a commitment to harnessing technology for the betterment of global health. Together, we can shape a future where AI serves as a catalyst for positive change in the MA world! What challenges do you foresee in implementing AI solutions in medical affairs? How can these challenges be addressed? #AI #ArtificialIntelligence #HealthcareInnovation #FutureofMedicalAffairs #MAPSPR24 #JoinTheMovement
To view or add a comment, sign in
-
-
Meet the #GenAICare consortium: Unlocking the power of AI in healthcare There’s no doubt: Generative Artificial Intelligence (AI) is improving our lives faster than any new technology before it. These AI tools became widely available only 20 months ago, and already we see that their potential is practically limitless. One of the most promising sectors is healthcare, where AI is even now being used to improve patient care, streamline clinical processes, and help healthcare professionals throughout the day – by reducing their admin burden and giving them the data and insights they need for better patient outcomes. To unlock the full transformative potential of AI-powered healthcare innovation, Microsoft is partnering with lifescience company #TeamBayer and healthcare professionals from across Europe to form the #GenAICare consortium. Together, we will help medical professionals to make best use of the power of AI – safely and responsibly. Together, we will accelerate the development of precision health and create a more efficient, personalised and patient-centric healthcare system.
To view or add a comment, sign in
-
-
Meet the #GenAICare consortium: Unlocking the power of AI in healthcare There’s no doubt: Generative Artificial Intelligence (AI) is improving our lives faster than any new technology before it. These AI tools became widely available only 20 months ago, and already we see that their potential is practically limitless. One of the most promising sectors is healthcare, where AI is even now being used to improve patient care, streamline clinical processes, and help healthcare professionals throughout the day – by reducing their admin burden and giving them the data and insights they need for better patient outcomes. To unlock the full transformative potential of AI-powered healthcare innovation, Microsoft is partnering with lifescience company #TeamBayer and healthcare professionals from across Europe to form the #GenAICare consortium. Together, we will help medical professionals to make best use of the power of AI – safely and responsibly. Together, we will accelerate the development of precision health and create a more efficient, personalised and patient-centric healthcare system.
To view or add a comment, sign in
-
-
🌐🔬 Reflecting on 'Data Workshop: Unlocking AI for Healthcare Transformation' at Nortal🌐🔬 Last week, I had the privilege of attending the 'Data Workshop: Unlocking AI for Healthcare Transformation' organized by Tehnopol HealthTech and Nortal. One of the standout speakers was Kertti Merimaa, Product Manager at Nortal, who shared her vision for the future of hospital information systems. 🔑 Key Takeaways from Kertti's Talk: 1️⃣ Patient-First Approach: The future of healthcare will pivot from being doctor-centric to patient-centric. 2️⃣ Evidence-Based Decision Making: Using #data and #AI as new collaboration tools to unify everyone around the same information field. 3️⃣ Preventive Measures: Shifting focus to prevention and delivering services where patients are, not just where hospitals are located. A question I often encounter about Nora AI is how ready people are for such innovative futures. Kertti's response, citing Estonia's e-prescription system, was super! The system minimizes direct interaction with technology itself, making it user-friendly and efficient. 💡This conversation resonated deeply with me. At Nora AI, we're developing a #drugdiscovery platform that aims to empower scientists globally. But how open are scientists to embracing this cutting-edge technology? Will they fear AI replacing them? My belief is firm: #AI can never replace the human touch. Nora is designed to enhance and unleash the true potential of #scientists, not to work in isolation. We're combining Nora's artificial intelligence with the power of the human brain to revolutionize drug discovery🤖🧠. As we move forward, it's not about AI replacing humans; it's about AI and humans working in synergy to achieve greater heights in #healthcare. #Tehnopol #Nortal #HealthcareInnovation #AI #DrugDiscovery #NoraAI #FutureOfHealthcare
To view or add a comment, sign in
-
Embracing the Healthcare Revolution: AI's Unprecedented Impact The transformational power of AI and digital tech in healthcare is unprecedented. It's reshaping the entire value chain, surpassing any prior industry developments. The present moment showcases the immense potential already harnessed and hints at what's yet to come. Witnessing AI's prowess in action within healthcare is awe-inspiring. Its current implementations are just the tip of the iceberg. The next decade holds the key to a future where AI's role will define healthcare's trajectory. Today's actions are shaping tomorrow's healthcare landscape. Let's navigate this pivotal era together, where every innovation today molds the future of healthcare. Join the conversation on the profound impact and boundless possibilities AI brings to our industry! #HealthcareInnovation #FutureofHealthcare #AIinHealthcare
To view or add a comment, sign in
-
Seasoned Medical Communications Leader | 25+ Years of Expertise in Pharma & Healthcare | Specialized in Driving Growth & Productivity | Proven Track Record in Strategic Partnerships & Innovative Solutions
Exciting news in the world of life sciences! 🚀 Introducing 4Sight by Envision Pharma Group–our innovative approach to integrating AI into the medical insights journey. We recognize that the success of AI tools lies in the people and processes behind them. 4Sight is crafted to empower medical affairs teams by transforming raw data into actionable insights. Welcome to the future of medical insights. Welcome to 4Sight by Envision. For more information contact me! #AI #LifeSciences #MedicalInsights #Innovation
Welcome to a new era of AI in life sciences. Today, we launch 4Sight by Envision, a transformative approach to embedding AI into the medical insights journey. We understand that the effectiveness of even the most advanced AI tools and platforms depends on the people and processes that support them. That’s why we introduce a new innovative way to enhance the industry. Our AI and technology-enabled offering is designed to help your medical affairs teams optimize raw data and transform it into actionable insights. By providing the right training, resources, and operating procedures, 4Sight helps your teams unlock the full potential of their data and insights. Together, we help you drive better healthcare outcomes for patients. Discover more. 👇 https://lnkd.in/engaZua7 #MedAffairs #AIinHealthcare #LifeSciences
Envision Pharma Group launches 4Sight to drive AI and technology performance in healthcare
To view or add a comment, sign in
-
Everyone nods in agreement about how AI can revolutionise healthcare but few will admit that they don't understand how it works. And here's the snag - if you don't understand how that algorithm came up with its conclusions and decisions, how much trust can you put in its accuracy? And in healthcare, where wrong information and wrong decisions can have fatal consequences, it is no wonder uptake of AI isn't as widespread as it should be. Ensuring you adhere to processes and techniques that result in explainable AI is critical in healthcare - whether that AI is deployed in drug discovery and development or deployed in treatment decision-making systems in clinic. What are the best practices for developing and implementing explainable AI? How do you ensure the AI models you're building are transparent, interpretable and accountable? What are the unintended consequences or risks of an opaque AI black box system, for pharma companies and for healthcare providers and how can explainable AI mitigate this? These are just a few key questions my two expert panellists - Andreas Kraemer and Anil Jain, both former IBM'ers! - will be answering in our live online event next Wednesday, May 29, 10amEST [free to register]. It should be a corker of a discussion. https://lnkd.in/eb4vhe8E #explainableAI #generativeAI #medicalAI #techbio #AIfordrugdiscovery #computationalbiology #healthAI #clinicalAI
To view or add a comment, sign in
-
-
Generative AI: Revolutionizing Healthcare 🚀 Imagine a future where AI doesn't just diagnose diseases faster but transforms how doctors work. That's the power of generative AI in healthcare! 📈 From $14.6 billion in 2023, the AI in Healthcare Market is set to skyrocket to $102.7 billion by 2032. Why? Because generative AI is not just a trend – it's a game-changer. 💰 With $1.7 billion invested in the last three years, VC firms are betting big on AI's potential in drug discovery and software coding. 🔬 By 2025, 50% of drug research will harness generative AI. That's not just growth; it's a revolution. 💡 Paul de Balincourt, a leader in Healthcare Data & AI, says generative AI is freeing up valuable human time for complex, high-value tasks. 🔓 This is more than just a shift; it's a leap forward for patients, healthcare providers, and pharma companies. #HealthcareAI #Innovation #FutureOfMedicine
To view or add a comment, sign in
-
Digital Health | Evidence Generation | Research Strategy | People Leader | Science Communicator | Behavioral Science | Recovered Academic
1moI just hope we're not just jumping on a bandwagon - everyone's talking about AI and there's a lot of buzz, but in healthcare we have a responsibility of considering the implications of biases that often exist in AI algorithms, the risks in generative AI, and people's preferences for how AI is actually used (e.g., there was some data suggesting people were uncomfortable with the idea of an "empathic" AI chatbot that tried to develop a relationship with them). I think we are in a strong position in digital health to ask these hard questions, explore impacts and potential solutions, and figure this all out - but we have to be willing to fight the push to jump on the bandwagon and to pause and ask the hard questions.